Mets Injury Crisis Deepens: Senga to IL, Soto's Arm Fragile, Robert's Back a Question Mark
By Justin Erickson ·
New York is fielding a MASH unit while the books are still pricing them like a contender.
As ESPN reported, the Mets placed Kodai Senga on the injured list Tuesday with lumbar spine inflammation — specifically around the L4 and L5 vertebrae — just the latest entry in a casualty log that is becoming impossible to ignore. Senga received an epidural and won't throw for 10 days minimum. He joins Francisco Lindor (calf, walking boot, timeline unknown) and Jorge Polanco (bruised wrist, IL) on the shelf, while Juan Soto is managing forearm tightness that has kept him anchored at DH, and Luis Robert Jr. sat out Tuesday with lower back pain that has yet to be tested. The Mets have lost 15 of their last 17 games. This isn't a slump — it's structural collapse.
Senga's injury is the most alarming development in isolation, but context makes it worse. He was already posting a 9.00 ERA over 20 innings this season, failing to complete four innings in each of his last three starts. The L4-L5 inflammation suggests the mechanical problems weren't just rust — there was likely a physical explanation for his diminished stuff and shortened outings. Christian Scott gets called up from Triple-A Syracuse to slot into Friday's start against the Angels, which is a significant downgrade in the rotation's already-thin depth. The Mets' pitching infrastructure is now visibly fraying at every level.
Soto's forearm situation deserves more scrutiny than it's getting. The discomfort emerged after a throwing session Friday, an MRI showed no structural damage, and manager Carlos Mendoza insists the swing isn't affected — but the Mets are keeping him at DH out of caution while the arm heals. That protective posture suggests the training staff isn't fully comfortable with the risk of outfield throws, which raises real questions about Soto's defensive timeline and whether this forearm issue lingers into May. Robert's back is similarly unresolved: no imaging yet, and Mendoza acknowledged testing remains on the table if symptoms don't improve within 48 hours.
From a betting standpoint, this roster situation points squarely at Mets team totals and run-line markets. The lineup is losing depth at shortstop, first base, and potentially two outfield spots simultaneously, while the rotation just swapped a struggling but established arm for a Triple-A callup. New York's offense has to carry more weight with less firepower, and their pitching can no longer paper over the gaps. Any Mets team total priced above 3.5 for games where Scott or a backend arm is starting deserves a hard look at the under. Robert's absence also weakens the middle of the order — his TB props and RBI lines are non-starters until back status clears. Soto's designation-hitter status keeps his hit and plate-appearance props intact for now, but monitor that forearm closely: a DH-only role caps his floor if production dips while he's protecting the arm.
The broader market risk is that oddsmakers are still processing this avalanche in real time. Mets moneyline prices haven't fully adjusted to reflect a rotation that now runs Scott into a competent Angels lineup, a lineup missing Lindor's on-base presence and Robert's pop. Fading New York on the run line over the next week — particularly in games where the opposing starter is a solid mid-rotation arm or better — is among the cleaner angles in the NL right now. Mendoza put it plainly: 'Nobody's going to feel sorry for us.' Neither should the betting market.